Washington, District of Columbia 20010


Purpose:

The objective of the KAROS study is to compare rehabilitation outcomes between 3 proposed protocols and a current standard of care protocol for the purpose of identifying better practice for outpatient rehabilitation among patients with single total knee replacement. The 3 advanced protocols involve use of an anti-gravity treadmill and/or the patterned electrical neuromuscular stimulation (PENS). Both medical modalities have been cleared by the FDA to be used in medical rehabilitation, including total knee replacement.


Criteria:

Inclusion Criteria: - Patients who undergo an elective single total knee arthroplasty and initiate their outpatient rehabilitation therapy within 3 weeks after surgery. - Patients who are 40 years old or older. - Patients who weight less than 320 lb to accommodate the weight limit to use the anti-gravity treadmill. Exclusion Criteria: - Patients who had any lower extremity joint replacement less than 1 year prior the current total knee replacement. - Patients who are pregnant or may be pregnant. - Patients who have a medical history of neurologic disorders. - Patients who have received more than 2 weeks of other formats of rehabilitation prior their outpatient rehabilitation program. - Patients who received any cancer treatment in the past year prior the current surgery. - Patients who have uncontrolled cardiovascular hypertension. - Patients who have cardiac demand pacemakers and/or implanted defibrillators.


NCT ID:

NCT02426190


Primary Contact:

Jean Hsieh, PhD
Phone: 202-877-1787
Email: jean.hsieh@medstar.net


Backup Contact:

N/A


Location Contact:

Washington, District of Columbia 20010
United States

Jean Hsieh, PhD
Phone: 202-877-1787
Email: jean.hsieh@medstar.net

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.